Reduction in Baseline CD4 Count Testing Following Human Immunodeficiency Virus “Treat All” Adoption in Uganda | Zendy

Esther Nasuuna | Zendy; Mark W. Tenforde | Zendy; Alex Muganzi | Zendy; Joseph N Jarvis | Zendy; Yukari C. Manabe | Zendy; Joanita Kigozi | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Reduction in Baseline CD4 Count Testing Following Human Immunodeficiency Virus “Treat All” Adoption in Uganda

Author(s) -

Esther Nasuuna,

Mark W. Tenforde,

Alex Muganzi,

Joseph N Jarvis,

Yukari C. Manabe,

Joanita Kigozi

Publication year - 2020

Publication title -

clinical infectious diseases

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 3.44

H-Index - 336

eISSN - 1537-6591

pISSN - 1058-4838

DOI - 10.1093/cid/ciaa261

Subject(s) - human immunodeficiency virus (hiv) , medicine , baseline (sea) , disease , immunology , stage (stratigraphy) , virology , biology , fishery , paleontology

Baseline CD4 testing rates declined from 73% to 21% between 2013 and 2018 with adoption of “Treat All” in Uganda. Advanced human immunodeficiency virus (HIV) disease (CD4 count < 200 cells/µL) remained common (24% of those tested in 2018, 83% of whom had World Health Organization stage I/II disease). Despite frequent presentation with advanced HIV disease, CD4 testing has declined dramatically.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research